Šalis: Jungtinės Valstijos
kalba: anglų
Šaltinis: NLM (National Library of Medicine)
PANCRELIPASE LIPASE (UNII: 8MYC33932O) (PANCRELIPASE LIPASE - UNII:8MYC33932O), PANCRELIPASE PROTEASE (UNII: 3560D81V50) (PANCRELIPASE PROTEASE - UNII:3560D81V50), PANCRELIPASE AMYLASE (UNII: YOJ58O116E) (PANCRELIPASE AMYLASE - UNII:YOJ58O116E)
Atlantic Biologicals Corps
ORAL
PRESCRIPTION DRUG
CREON (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions. ® None. Teratogenic effects Pregnancy Category C: Animal reproduction studies have not been conducted with pancrelipase. It is also not known whether pancrelipase can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. CREON should be given to a pregnant woman only if clearly needed. The risk and benefit of pancrelipase should be considered in the context of the need to provide adequate nutritional support to a pregnant woman with exocrine pancreatic insufficiency. Adequate caloric intake during pregnancy is important for normal maternal weight gain and fetal growth. Reduced maternal weight gain and malnutrition can be associated with adverse pregnancy outcomes. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, cauti
New Drug Application
Atlantic Biologicals Corps ---------- MEDICATION GUIDE CREON®(krē ′ŏn) (pancrelipase) Delayed-Release Capsules Read this Medication Guide before you start taking CREON and each time you get a refill. There may be new information. This information does not take the place of talking to your doctor about your medical condition or treatment. What is the most important information I should know about CREON? CREON may increase your chance of having a rare bowel disorder called fibrosing colonopathy. This condition is serious and may require surgery. The risk of having this condition may be reduced by following the dosing instructions that your doctor gave you. Call your doctor right away if you have anyunusual or severe: • stomach area (abdominal) pain • bloating • trouble passing stool (having bowel movements) • nausea, vomiting, or diarrhea Take CREON exactly as prescribed. Do not take more or less CREON than directed by your doctor. What is CREON? CREON is a prescription medicine used to treat people who cannot digest food normally because their pancreas does not make enough enzymes due to cystic fibrosis, swelling of the pancreas that lasts a long time (chronic pancreatitis), removal of some or all of the pancreas (pancreatectomy), or other conditions. CREON may help your body use fats, proteins, and sugars from food. CREON contains a mixture of digestive enzymes including lipases, proteases, and amylases from pig pancreas. What should I tell my doctor before taking CREON? Before taking CREON, tell your doctor about all your medical conditions, including if you: • are allergic to pork (pig) products • have a history of intestinal blockage of your intestines, or scarring or thickening of your bowel wall (fibrosing colonopathy) • have gout, kidney disease, or high blood uric acid (hyperuricemia) • have trouble swallowing capsules • have any other medical condition • are pregnant or plan to become pregnant. It is not known if CREON will harm your unborn baby. • are breast-feeding or plan to Perskaitykite visą dokumentą
CREON- PANCRELIPASE CAPSULE, DELAYED RELEASE PELLETS ATLANTIC BIOLOGICALS CORPS ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE CREON SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR CREON. CREON (PANCRELIPASE) DELAYED-RELEASE CAPSULES FOR ORAL USE INITIAL U.S. APPROVAL: 2009 RECENT MAJOR CHANGES Dosage and Administration, ( ) 6/2011 _Infants (up to 12 months)_2.1 Dosage and Administration ( ) 6/2011 2.2 Dosage and Administration, ( ) 6/2011 _Infants (up to 12 months)_2.2 INDICATIONS AND USAGE CREON is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions. ( ) 1 DOSAGE AND ADMINISTRATION CREON is not interchangeable with any other pancrelipase product. ( ) 2.1 Do not crush or chew capsules and capsule contents. For infants or patients unable to swallow intact capsules, the contents may be sprinkled on soft acidic food, e.g., applesauce. ( ) Dosing should not exceed the recommended maximum dosage set forth by the Cystic Fibrosis Foundation Consensus Conferences Guidelines. ( ) 2.12.2 _Infants (up to 12 months)_ Prior to each feeding, infants may be given 3,000 lipase units (one capsule) per 120 mL of formula or per breast- feeding. ( ) 2.1 Do not mix CREON capsule contents directly into formula or breast milk prior to administration. ( ) 2.1 _Children Older than 12 Months and Younger than 4 Years_ Begin with 1,000 lipase units/kg of body weight per meal for children less than age 4 years to a maximum of 2,500 lipase units/kg of body weight per meal (or less than or equal to 10,000 lipase units/kg of body weight per day), or less than 4,000 lipase units/g fat ingested per day. ( ) 2.2 _Children 4 Years and Older and Adults_ Begin with 500 lipase units/kg of body weight per meal for those older than age 4 years to a maximum of 2,500 lipase units/kg of body weight per meal (or less t Perskaitykite visą dokumentą